CARY, N.C., Aug. 8, 2025 Heron Therapeutics, Inc. (HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the completion of a comprehensive capital restructuring ...

Management uses certain key financial measures, some of which are not prescribed under U.S. GAAP rules and standards (“non-GAAP financial measures”), to evaluate our financial performance, financial ...

In an increasingly fragmented and complex global economy, the traditional approach of capital allocation—dividing assets across equities, bonds and alternatives—is no longer sufficient to meet the ...

FRIEDBERG, Germany--(BUSINESS WIRE)-- Today, voxeljet AG (the “Company”) announced that at today’s general meeting, the resolution proposal to approve the sale of the business of voxeljet AG to ...

US-based asset management firm TPG Capital is nearing a deal to acquire around 40% stake in India's financial services firm ...

Brighthouse Financial Stockholders to Receive $70.00 per share in $4.1 Billion Transaction; Positions Brighthouse Financial for Strategic Long-Term Growth NEW YORK & CHARLOTTE, N.C.--(BUSINESS ...

Company Projects Substantial Net Income Expansion Supported by Debt-Free Balance Sheet, ~ $4M Yerbaé Contribution, and Majority Revenue Interest in BONK.fun SCOTTSDALE, AZ / ACCESS Newswire / December ...

PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT) (the “Company”), inventor of Cellvizio ®, the multidisciplinary probe and needle-based confocal laser ...

Three co-founders with experience across investment management for ultra-high-net-worth clients, alternative asset management and private banking have launched a New York-based registered investment ...

Mauna Kea Technologies (Euronext Growth: ALMKT) (the “Company”), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced ...